Professor Ajay Vora is a Consultant Paediatric Haematologist at Great Ormond Street Hospital for Children in London, specialising in childhood leukaemia, blood disorders, and haematopoietic stem cell transplantation. He has a long-standing career in paediatric haematology and has contributed to clinical research and treatment development in childhood blood cancers.

Professor Vora has been a Consultant Paediatric Haematologist at Great Ormond Street Hospital since 2017. He has also held a consultant position at Sheffield Children's Hospital since 1995 and has been a professor of paediatric haematology at Sheffield University since 2005.

His principal clinical interests include childhood leukaemia, cord blood transplantation, and the management of malignant and non-malignant blood disorders in children. His work covers conditions requiring highly specialised haematological diagnosis, chemotherapy, transplantation, supportive care, and long-term follow-up.

Professor Vora has played an important role in clinical trials involving childhood acute lymphoblastic leukaemia (ALL) and haematopoietic stem cell transplantation. GOSH reports that he has served as Chief Investigator for several national and international phase three clinical trials and Principal Investigator for more than 20 trials.

Clinical research is an important component of his professional work. His research has focused on improving treatment approaches for children with leukaemia and evaluating ways of reducing treatment-related complications while maintaining effective disease control.

Bone marrow and stem cell transplantation can form an important part of treatment for selected children with high-risk or relapsed blood cancers and certain non-malignant blood disorders. Such procedures require specialised teams covering transplantation, infectious disease management, immunology, transfusion medicine, nursing, and long-term follow-up.

Professor Vora has also been involved in research exploring alternatives and improvements to conventional chemotherapy. GOSH reported his involvement in a clinical trial offering children with cancer an alternative treatment approach designed to reduce some of the burdens associated with conventional chemotherapy.

His academic contribution includes a substantial publication record. GOSH reported that Professor Vora has approximately 400 publications, including peer-reviewed research, reviews, books, and book chapters related to childhood cancer and paediatric haematology.

He has held leadership roles in national and international childhood leukaemia research. GOSH notes that he previously chaired the UK NCRI childhood leukaemia subgroup and the International Berlin-Frankfurt-Münster Acute Lymphoblastic Leukaemia Committee. These roles reflect his long involvement in collaborative research into childhood blood cancers.

Professor Vora was recognised with an MBE in the King's New Year Honours for services to childhood leukaemia. GOSH reported the award in December 2024 and highlighted his contributions to improving treatment and research in paediatric blood cancer.

For families considering specialist childhood cancer treatment, his areas of expertise may be relevant to acute lymphoblastic leukaemia, other childhood blood cancers, non-malignant blood disorders, and cases where stem cell transplantation is being considered.

Children receiving treatment for leukaemia often require coordinated care involving paediatric haematologists, oncologists, transplant specialists, laboratory teams, radiologists, pharmacists, nurses, psychologists, and rehabilitation professionals. The precise treatment plan depends on the child's diagnosis, disease risk, response to therapy, genetic findings, and previous treatment.

International patients should obtain current referral information directly from Great Ormond Street Hospital. Medical records, pathology reports, imaging, laboratory results, treatment history, and transplantation information may be required for specialist assessment.

Professor Ajay Vora's extensive experience in paediatric haematology, childhood leukaemia, transplantation, and clinical research makes his profile particularly relevant to families seeking specialist children's blood-cancer services at GOSH.